WALTHAM, Mass.--(BUSINESS WIRE)--NeurAxon Inc., a developer of next-generation pain therapeutics, today announced the appointment of Thomas Lategan, DPhil to the position of Vice President, Regulatory Affairs for the Company. Dr. Lategan was most recently Vice President, Regulatory Affairs of Panacos Pharmaceuticals, Inc., where he was responsible for interactions with the Food and Drug Administration (FDA), establishing regulatory compliance and heading project management for the company’s lead drug candidate. Dr. Lategan has over twenty years of experience in pharmaceutical regulatory affairs and project management.
